Applications
Online Inquiry

For research use only. Not intended for any clinical use.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Non-Human Primate (NHP) Applications by Disease Areas

Harnessing the power of nonhuman primate (NHP) models for your next breakthrough? Accelerate Your Drug Discovery Process! Are you currently facing long drug development cycles, difficulty in predicting clinical outcomes, or challenges with regulatory submissions for advanced therapies? Creative Biolabs helps you accelerate drug discovery and streamline clinical trial processes through our advanced preclinical research platforms and deep expertise in NHP models.

Advancing Research: Tailored NHP Solutions Across Disease Domains

A comprehensive guide to leveraging nonhuman primate models in preclinical research for various disease areas, from neurological disorders to oncology.

Get a Quote

Overview of NHP Applications

What Are Our Research Areas?

Preclinical research is the crucial phase where new drugs, therapies, and vaccines are rigorously tested to determine their safety and efficacy before human trials. Nonhuman primate models are indispensable in this stage due to their high degree of genetic, immunological, and physiological similarity to humans. Creative Biolabs leverages these models to support a broad spectrum of research areas, including:

  • Neurological Disorders: The complex brain structure and function of NHPs allow for the study of neurodegenerative diseases like Alzheimer's and Parkinson's, as well as the development of novel treatments for conditions such as glioblastoma.
  • Oncology & Immunotherapy: NHPs are vital for modeling tumor microenvironments, evaluating the safety of complex biologics like CAR-T therapies, and testing the efficacy of immunotherapies and cancer vaccines.
  • Infectious Diseases: The unique predictive relevance of NHPs has been essential for developing vaccines and therapies for infectious diseases, including COVID-19, HIV/AIDS, Ebola, and Zika.
  • Cardiometabolic & Inflammatory Diseases: NHPs naturally develop age-related comorbidities like diabetes and dyslipidemia, making them superior models for understanding the progression of cardiovascular diseases and for testing therapeutic interventions.
  • Ophthalmic & Pulmonary Disorders: The anatomical and functional similarities of NHP visual and respiratory systems to humans make them the gold standard for testing gene therapies, surgical techniques, and other treatments for blinding diseases and pulmonary conditions.
  • Fibrosis & Rare Diseases: NHPs are used to model fibrotic conditions and rare diseases where other animal models cannot replicate the complex multiorgan interactions and integrated biology seen in humans.

Why Choose Us?

Creative Biolabs' NHP models offer distinct advantages that are critical for modern drug discovery:

  • Genetic/Immunological Similarities: NHPs share up to 98% of their genetic makeup with humans, providing a highly relevant model for studying human-specific diseases and immune responses.
  • Clinical Translational Relevance: Data from NHP studies is highly predictive of human outcomes, reducing the risk of costly and time-consuming failures in clinical trials.
  • Data Types Required for Regulatory Submissions: Regulatory bodies often require data from NHP studies, particularly for advanced therapies like gene and cell therapies, making them a non-negotiable step in the drug development process.
  • Complex Integrated Biology: NHPs are the only models that can replicate the multiorgan interactions and systemic effects required to fully evaluate the safety and efficacy of certain therapies.

Distributed under Unsplash License, from Unsplash.

Key Applications

Nonhuman primate models are applied with precision to address specific research questions across disease areas:

  • Gene Therapy: NHPs are used for vector biodistribution and shedding studies to understand where a gene therapy is delivered and how long it persists.
  • Immunotherapy: They are critical for modeling cytokine release syndrome (CRS) and other immune-related adverse events for CAR-T and bispecific antibody therapies.
  • Infectious Disease: NHP models are utilized for vaccine challenge and protection studies, allowing for a realistic assessment of a vaccine's ability to prevent infection.
  • Oncology: They are used for tumor microenvironment studies, which provide invaluable insights into how a drug interacts with the complex system surrounding a tumor, particularly for immune checkpoint inhibitor (ICI) evaluation.

How Do Creative Biolabs Support Your Projects?

Creative Biolabs offers a suite of comprehensive services designed to support every stage of your NHP-based research, ensuring high-quality data and robust study design.

Service Capability Corresponding Application Area
Biological Collection & Biobanking Providing high-quality biospecimens for early-stage discovery and biomarker analysis.
DMPK & PK/PD Evaluation Providing preclinical PK/PD evaluation to accelerate your drug discovery & development process.
Pharmacology & Efficacy For Neurological Disorders, Metabolic Diseases, Cardiovascular Diseases, and more, providing robust disease models to evaluate your therapy's effectiveness.
Bioanalysis & Biomarker Offering detailed insights into drug concentration and target engagement.

Translational Impact

Leveraging Creative Biolabs' NHP models offers a powerful advantage in your drug development pipeline. Our studies provide more reliable early proof of concept, allowing for early detection of potential immune responses or toxicities. This data-driven approach significantly reduces the risk of IND (Investigational New Drug) application failure. For advanced therapies, NHP biodistribution and safety data are often a mandatory requirement for regulatory submissions to agencies.

Frequently Asked Questions

Q: How do your NHP models compare to alternative in silico or in vitro models?
A: While in silico and in vitro methods are valuable for initial screening, they cannot fully replicate the complex, integrated biological systems of a living organism. NHPs offer a unique advantage by providing a holistic view of a therapy's safety and efficacy, including multiorgan interactions, immune responses, and long-term effects that are critical for predicting human outcomes.
Q: What specific cell sources and sample stability can you provide from NHPs?
A: Creative Biolabs' NHP Bio-specimen Bank offers a wide range of high-quality, fully characterized biospecimens, including blood, serum, plasma, PBMCs, immune cells, and frozen tissues. Our expert team ensures proper collection and cold-chain transportation, guaranteeing the stability and integrity of every sample.
Q: How do you address the ethical and logistical considerations of using NHP models?
A: Our work is conducted under the most stringent ethical guidelines and regulatory oversight. We prioritize animal welfare and employ best practices to ensure every study is humane and justifiable. Our experienced logistics team handles all aspects of sample management, from collection to final delivery, ensuring compliance and peace of mind for our clients.

Contact Us

Creative Biolabs is a leader in preclinical research, providing a comprehensive and integrated platform for leveraging nonhuman primate models to accelerate your drug discovery and development efforts. Our deep expertise, robust service offerings, and commitment to scientific excellence are your strategic advantage. Contact and leverage our NHP applications for your next study.

Cart
Cart